Thanks. May I just correct you? It's just Mr.; I'm not a doctor.
Canada invented, as I understand it, the whole business of medical radioisotopes. As you know, the NRU has been a very solid producer of radioisotopes for many years. We do have a long history of producing radioisotopes. I suspect, and Mr. West will undoubtedly give you the figures, it's probably a lucrative business being the suppliers of radioisotopes. Whether it's a lucrative business at the beginning of the production phase, it's not clear to me--that is, when you're running it as a reactor and you're producing material in the reactor itself. So whether there's an economic advantage, that I don't know.
One of the difficulties in producing isotopes, and this was a difficulty that MAPLE was intended to resolve, is when you do it in a research reactor, you are always having competing demands on that reactor, and this is the same for all the reactors around the world. Research reactors are designed for research, and the management process you put in for research is quite different. You hire the brightest and the best you can. You give them the greatest freedom you can to do their research. When you're doing something in production, this is a focused business. So there's always a problem there. Of course MAPLE was intended to solve that issue, which is one of the advantages of the MAPLE design originally.
Speaking as a Canadian, I would be very sorry to see us out of that business, given our history.